The Ecstasy and Agony of Assay Interference Compounds.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2017-02-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.7b00229PMID 28244745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.

  2016cited by this paper
• How to Triage PAINS-Full Research

  2016cited by this paper
• Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research.

  2016cited by this paper
• Badapple: promiscuity patterns from noisy evidence

  2016cited by this paper
• Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).

  2016cited by this paper
• Docking studies on the interaction of flavonoids with fat mass and obesity associated protein.

  2015cited by this paper
• Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?

  2015cited by this paper
• Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase

  2015cited by this paper
• Screening-based translation of public research encounters painful problems.

  2015cited by this paper
• Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation.

  2015cited by this paper
• Structure-based discovery of an immunomodulatory inhibitor of TLR1-TLR2 heterodimerization from a natural product-like database.

  2015cited by this paper
• An Aggregation Advisor for Ligand Discovery.

  2015cited by this paper
• Degradation of Curcumin: From Mechanism to Biological Implications.

  2015cited by this paper
• The promise and peril of chemical probes.

  2015cited by this paper
• Chemistry: Chemical con artists foil drug discovery

  2014cited by this paper
• Phytochemicals Perturb Membranes and Promiscuously Alter Protein Function

  2014cited by this paper
• Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors

  2013cited by this paper
• Metrics other than potency reveal systematic variation in responses to cancer drugs.

  2013cited by this paper
• Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter.

  2012cited by this paper
• Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors.

  2012cited by this paper
• Colloidal Aggregation Affects the Efficacy of Anticancer Drugs in Cell Culture

  2012cited by this paper
• Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.

  2011cited by this paper
• Fluorescence polarization assays in small molecule screening

  2011cited by this paper
• Apparent activity in high-throughput screening: origins of compound-dependent assay interference.

  2010cited by this paper
• Observations on screening-based research and some concerning trends in the literature.

  2010cited by this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cited by this paper
• Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.

  2010cited by this paper
• Divergent modes of enzyme inhibition in a homologous structure-activity series.

  2009cited by this paper
• Small-Molecule Activators of a Proenzyme

  2009cited by this paper
• Fluorescence spectroscopic profiling of compound libraries.

  2008cited by this paper
• Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.

  2008cited by this paper
• Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.

  2008cited by this paper
• A high-throughput screen for aggregation-based inhibition in a large compound library.

  2007cited by this paper
• Chemical probes of UDP-galactopyranose mutase.

  2006cited by this paper
• A detergent-based assay for the detection of promiscuous inhibitors

  2006cited by this paper
• Interpreting steep dose-response curves in early inhibitor discovery.

  2006cited by this paper
• Screening in a spirit haunted world.

  2006cited by this paper
• High-throughput assays for promiscuous inhibitors

  2005cited by this paper
• A guide to drug discovery: Designing screens: how to make your hits a hit

  2003cited by this paper
• Nonleadlikeness and leadlikeness in biochemical screening.

  2003cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper

• Old Target with New Vision: In Search of New Therapeutics for Diabetic Retinopathy by Selective Modulation of Aldose Reductase

  2026cites this paper
• WRN structural flexibility showcased through fragment-based lead discovery of inhibitors

  2026cites this paper
• Novel SARS-CoV-2 allosteric inhibitors that destabilize the Main Protease Mpro dimer.

  2025cites this paper
• Development of 9-cinnamyl-9H-purine derivatives as potent anticancer agents through inactivation of NF-κb/p65 and p-STAT1 signaling pathways: Discovery of a new template for adenosine receptor.

  2025cites this paper
• Rational Design and Synthesis of Highly Stable Haloflavanone DNA Methyltransferase Inhibitors Inducing Tumor Suppressor Gene Re-expression in Cancer Cells.

  2025cites this paper
• Pamoic acid and carbenoxolone specifically inhibit CRISPR/Cas9 in bacteria, mammalian cells, and mice in a DNA topology-specific manner

  2025cites this paper
• Discovery of Covalent and Cell-Active ALKBH5 Inhibitors with Potent Antileukemia Effects In Vivo.

  2025cites this paper
• Letting Go of Pains and Other Dogmas

  2025cites this paper
• Exploring Arylidene-Indolinone Ligands of Autophagy Proteins LC3B and GABARAP.

  2025cites this paper
• Target agnostic cellular screening in the era of chemically induced proximity.

  2025cites this paper
• Development of Lipopeptides as Orthoflavivirin Inhibitors with Low Micromolar Broad-Spectrum Antiorthoflaviviral Activity

  2025cites this paper
• Silybin, silychristin and silydianin are potential novel plant-based Pannexin1 channel inhibitors.

  2025cites this paper
• Exploring Arylidene-Indolinone Ligands of Autophagy Proteins LC3B and GABARAP

  2024cites this paper
• Exploring the Protein Target Fishing Method in Classroom Computer Projects

  2024cites this paper
• Glycomimetics as Candidates for Treatment and Prevention of Catheter-associated Biofilms Formed by Pseudomonas aeruginosa.

  2024cites this paper
• Identification of Novel Human 15-Lipoxygenase-2 (h15-LOX-2) Inhibitors Using a Virtual Screening Approach

  2024cites this paper
• Paracatalytic induction: Subverting specificity in hedgehog protein autoprocessing with small molecules.

  2023cites this paper
• Synthesis of 9-Cinnamyl-9H-purine Derivatives as Novel TLR4/MyD88/NF-κB Pathway Inhibitors for Anti-inflammatory Effects.

  2023cites this paper
• Spiropiperidine-Based Oligomycin-Analog Ligands To Counteract the Ischemia–Reperfusion Injury in a Renal Cell Model

  2023cites this paper
• Discovery of Novel 8-Hydroxyquinoline Derivatives with Potent In Vitro and In Vivo Antifungal Activity.

  2023cites this paper
• Screening for bilayer-active and likely cytotoxic molecules reveals bilayer-mediated regulation of cell function

  2023cites this paper
• Molecular networking unveils anti-SARS-CoV-2 constituents from traditionally used remedies.

  2023cites this paper
• [3H]UR-JG102-A Radiolabeled Cyclic Peptide with High Affinity and Excellent Selectivity for the Neuropeptide Y Y4 Receptor.

  2023cites this paper
• Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor

  2023cites this paper
• Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes.

  2023cites this paper
• A meditation on accelerating the development of small molecule medicines targeting RNA

  2022cites this paper
• In Silico Identification of Multi-Target Ligands as Promising Hit Compounds for Neurodegenerative Diseases Drug Development

  2022cites this paper
• The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use

  2022cites this paper
• On drug discovery against infectious diseases and academic medicinal chemistry contributions

  2022cites this paper
• Tideglusib Inhibits Pif1 Helicase of Bacteroides sp. via an Irreversible and Cys-380-Dependent Mechanism

  2022cites this paper
• Maximizing the integration of virtual and experimental screening in hit discovery

  2022cites this paper
• Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach

  2022cites this paper
• Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19

  2022cites this paper
• Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19

  2022cites this paper
• Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies.

  2022cites this paper
• Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety.

  2022cites this paper
• Nuisance compounds in cellular assays.

  2021cites this paper
• Evolution of assay interference concepts in drug discovery

  2021cites this paper
• Synthesis, characterization, and evaluation of antioxidant and antimicrobial activity of three novel n-heteroaromatic hydrazonyl-thiazoles

  2021cites this paper
• Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer cells with evaluation of designed analogues.

  2021cites this paper
• Computationally Assisted Lead Optimization of Novel Potent and Selective MAO-B Inhibitors

  2021cites this paper
• Cinnamic acid/β-ionone hybrids: synthesis and in vitro anticancer activity evaluation

  2021cites this paper
• Highly efficient whole-cell biosynthesis and cytotoxicity of esculin esters.

  2021cites this paper
• N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants.

  2021cites this paper
• Fine-tuning of a generative neural network for designing multi-target compounds

  2021cites this paper
• Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2

  2021cites this paper
• RNase P Inhibitors Identified as Aggregators

  2021cites this paper
• Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles

  2021cites this paper
• Structure–activity relationship of ipglycermide binding to phosphoglycerate mutases

  2021cites this paper
• Multifunctional agents based on benzoxazolone as promising therapeutic drugs for diabetic nephropathy.

  2021cites this paper
• A Crowding Barrier to Protein Inhibition in Colloidal Aggregates.

  2021cites this paper
• Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation.

  2021cites this paper
• Preparing (Metalla)carboranes for Nanomedicine

  2021cites this paper
• Tideglusib and its analogs as inhibitors of Staphylococcus aureus SrtA.

  2020cites this paper
• Nanoparticle-based formulation of metallacarboranes with bovine serum albumin for application in cell cultures

  2020cites this paper
• 1,3-Dipolar cycloaddition, HPLC enantioseparation and docking studies of saccharin/isoxazole and saccharin/isoxazoline derivatives as selective carbonic anhydrase IX and XII inhibitors.

  2020cites this paper
• Natural allosteric modulators and their biological targets: molecular signatures and mechanisms.

  2020cites this paper
• Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of N ω-carbamoyl substituents determines Y1R binding mode and affinity.

  2020cites this paper
• Red-emitting dibenzodiazepinone derivatives as fluorescent dualsteric probes for the muscarinic acetylcholine M2 receptor.

  2020cites this paper
• Resurrecting the phoenix: When an assay fails.

  2020cites this paper
• Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro

  2020cites this paper
• Discovery of the first Vitamin K analog as a potential treatment of pharmacoresistant seizures.

  2020cites this paper
• High-Throughput Screening For The Discovery Of Enzyme Inhibitors.

  2020cites this paper
• Design, Synthesis, Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with Anti-Osteoarthritic Activity in Vivo.

  2020cites this paper
• Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors.

  2020influential citation
• Scouting around 1,2,3,4‐Tetrahydrochromeno[3,2‐c]pyridin‐10‐ones for Single‐ and Multitarget Ligands Directed towards Relevant Alzheimer's Targets

  2020cites this paper
• Prediction of Promiscuity Cliffs Using Machine Learning

  2020cites this paper
• Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based In Silico and In Vitro Assays

  2020cites this paper
• Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-in-Human Study in Postmenopausal Women.

  2020cites this paper
• Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors.

  2020cites this paper
• Discovery of an Inhibitor for Bacterial 3-Mercaptopyruvate Sulfurtransferase that Synergistically Controls Bacterial Survival.

  2020cites this paper
• Identification of benzo[cd]indol-2(1H)-ones as novel Atg4B inhibitors via a structure-based virtual screening and a novel AlphaScreen assay.

  2019cites this paper
• Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells.

  2019cites this paper
• Protein stability effects in aggregate-based enzyme inhibition.

  2019cites this paper
• Identification of novel small-molecule inhibitors of α-methylacyl-CoA racemase (AMACR; P504S) and structure-activity relationships.

  2019cites this paper
• [3H]UR-DEBa176: A 2,4-Diaminopyrimidine-Type Radioligand Enabling Binding Studies at the Human, Mouse, and Rat Histamine H4 Receptors.

  2019cites this paper
• Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings

  2019influential citation
• A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification.

  2019cites this paper
• Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.

  2019cites this paper
• An appraisal of natural products active against parasitic nematodes of animals

  2019cites this paper
• De-risking drug discovery of intracellular targeting peptides: screening strategies to eliminate false-positive hits

  2019cites this paper
• In search of safe pain relief: The analgesic and anti-inflammatory activity of phytosteryl ibuprofenates.

  2019cites this paper
• Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty Acid Derivatives Inhibit Mycobacterium avium subsp. paratuberculosis Growth

  2019cites this paper
• Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M2R Selectivity.

  2019cites this paper
• Small-Molecule Inhibitors of Haemophilus influenzae IgA1 Protease.

  2019cites this paper
• Recent Progress in Structure-Based Evaluation of Compound Promiscuity

  2019cites this paper
• Colloidal Drug Aggregate Stability in High Serum Conditions and Pharmacokinetic Consequence.

  2019cites this paper
• Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure.

  2019cites this paper
• The Distribution of Standard Deviations Applied to High Throughput Screening

  2019cites this paper
• Discovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine γ-Lyase.

  2019cites this paper
• Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40–CD154 Costimulatory Protein-Protein Interaction

  2018cites this paper
• Be Aware of Aggregators in the Search for Potential Human ecto-5′-Nucleotidase Inhibitors

  2018influential citation
• Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).

  2018cites this paper
• Binding Moiety Mapping by Saturation Transfer Difference NMR.

  2018cites this paper
• PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.

  2018cites this paper
• Selenazolyl-hydrazones as Novel Selective MAO Inhibitors With Antiproliferative and Antioxidant Activities: Experimental and In-silico Studies

  2018cites this paper
• Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.

  2018cites this paper
• Structure-Guided Synthesis and Mechanistic Studies Reveal Sweetspots on Naphthyl Salicyl Hydrazone Scaffold as Non-Nucleosidic Competitive, Reversible Inhibitors of Human Ribonucleotide Reductase.

  2018cites this paper
• X-ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential.

  2018cites this paper
• Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.

  2018cites this paper